Dr Spyros Retsas
Health Care Professional, Medicine And Medical Sciences
United Kingdom
My Publications
Sentinel node biopsy confers no added protection to patients with melanoma
Journal of the Royal Society of Medicine
August 2007
A “surgical” staging procedure in any cancer becomes essential when it provides unique information that influences the management of a particular cancer to the benefit and welfare of the patient. T...
Randomised clinical trials in Cancer Research
Journal of Clinical Oncology
December 2004
Ethical considerations and concerns in allocating at random, treatment or indeed placebo, to patients afflicted with cancer. Will progress in cancer treatment suffer if randomised trials were aband...
can viruses cause melanoma?
Melanoma Research
August 2004
Clinical observations on the behaviour of cutaneous melanoma are indicative of viral involvement in the induction and progression of this neoplasm
The origins, etymology and meaning of metastasis in the context of cancer.
ESMO Open
July 2017
Metastasis, in Greek, means removal or migration, dislocation, but also departing from life. Plato and Aristotle used the term metastasis to discuss the change, by revolution or transition, of a po...
Geotherapeutics: the medicinal use of earths, minerals and metals from antiquity to the...
Geological Society London Special Publications
December 2016
In antiquity, therapeutic empiricism attributed medicinal properties to animal products, plants, minerals and metals, including the soil of specific geographic locations. The therapeutic use of cer...
Ipilimumab and Vemurafenib in melanoma
Journal of the Royal Society of Medicine
June 2011
This study evaluates early reports on two novel treatments and their impact on the management of metastatic melanoma : 1) Ipilimumab which targets the cytotoxic T-lymphocyte-associated antigen ...
Medical experiments in antiquity
The Lancet
August 2010
Although the medical experiment is considered the product of the European Renaissance, Galen conducted and thoroughly described medical experiments, one of which is briefly described in this commun...
In Reply:
Journal of Clinical Oncology
July 2005
Prognostic factors of cutaneous melanoma and a new staging system proposed by the Ameri...
European Journal of Cancer
March 2002
Adjuvant therapy of malignant melanoma: is there a choice?
Critical Reviews in Oncology/Hematology
November 2001
Serum S100β Protein as a Marker of Disease Activity in Patients with Malignant Melanoma
Cancer Immunology Immunotherapy
January 2001
Melanoma and additional primary cancers
Melanoma Research
April 2000
Adjuvant therapy of melanoma
The Lancet
August 1998
Taxol and vinorelbine: a new active combination for disseminated malignant melanoma
Anti-Cancer Drugs
February 1996
Cutaneous Melanoma-associated Retinopathy
Ophthalmology
November 1994
Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adju...
Cancer
April 1994
Central nervous system lnvolvement in malignant melanoma
Cancer
May 1988
Cerebral metastases from melanoma can respond to chemotherapy with or without combination with radiotherapy.
EARLY OR LOW-GRADE MELANOMA?
The Lancet
August 1987
Missed malignant melanoma
BMJ
July 1986
Missed malignant melanoma
BMJ
May 1986
Sun beds and melanoma.
BMJ
March 1983
Pigment streaks in the nail plate due to secondary malignant melanoma
British Journal of Dermatology
March 1983
Vindesine as a single agent in the treatment of advanced malignant melanoma
Cancer Chemotherapy and Pharmacology
January 1979
Insulin abuse by a drug addict.
BMJ
December 1972
Successful bone marrow transplant for Fanconi's anaemia.
BMJ
February 1977
Gods behaving badly
Journal of Medical Biography
October 2013
The definition of Asclepiad Hippocrates and his alleged descent from the family line of Aesculapius
Alexander the Great and his interest in medicine
Journal of Medical Biography
August 2009
The article addresses medical aspects of Alexander's Asian campaign, the multiple injuries that he sustained in battle and the role of eponymous physicians and military surgeons involved in the tre...
Adjuvant vindesine in metastatic melanoma
Melanoma Research
April 2009
A critique of a randomised trial inadequately analysed for prognostic factors.
Heredopathia atactica polyneuritiformis: Refsum's disease
Acta Neurologica Scandinavica
January 2009
Reflecting on the 2001 American Joint Committee on Cancer Staging System for Melanoma
Seminars in Oncology
December 2007
Sentinel node biopsy confers no added protection to patients with melanoma
Journal of the Royal Society of Medicine
August 2007
INV 9 Prognostic factors of cutaneous melanoma and the latest staging system of the Ame...
Melanoma Research
February 2007
Integration of gamma knife surgery in the management of cerebral metastases from melanoma
Melanoma Research
February 2006
Cutaneous melanoma
The Lancet
June 2005
Cutaneous melanoma
The Lancet
June 2005
12 Systemic treatment of metastatic melanoma: current options
Melanoma Research
August 2004
P-13 Serum HER-2/neu concentrations in metastatic melanoma
Melanoma Research
August 2004
Report on the 5th International Conference on the Adjuvant Therapy of Malignant Melanom...
Melanoma Research
August 2004
Systemic Treatments For Metastatic Melanoma
Melanoma Research
April 2004
The CDKN2A tumour suppressor gene
Melanoma Research
December 2002
Report on the 4th International Conference on the Adjuvant Therapy of Malignant Melanom...
Melanoma Research
June 2002
Overexpression of HER-2 in thick melanoma
Melanoma Research
April 2002
Prognostic factors in therapeutic lymphadenectomy in melanoma
Melanoma Research
June 2001
What is the Optimal Therapy of Brain Metastases?
Clinical Oncology
April 2001
What is the Optimal Therapy of Brain Metastases?
Clinical Oncology
March 2001
In Vitro Cytotoxicity of Norviburtinal and Isopinnatal from Kigelia pinnata Against Can...
Planta Medica
December 2000
Oxaliplatin is active in vitro against human melanoma cell lines: comparison with cispl...
Anti-Cancer Drugs
November 2000
Melanoma and additional primary cancers
Melanoma Research
April 2000
Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advance...
Melanoma Research
August 1999
9 Melanoma and additional primary cancers
Melanoma Research
June 1999
O10 Serum S-100 protein as a marker of disease activity in malignant melanoma (MM)
Melanoma Research
June 1999
P29 Detection of tyrosinase mRNA by RT-PCR in peripheral blood of patients with melanoma
Melanoma Research
June 1999
24 Adjuvant therapy for malignant melanoma. Is there a choice?
Melanoma Research
June 1999
Sentinel-Lymph-Node Biopsy
New England Journal of Medicine
January 1999
Dissection of regional lymph nodes in cutaneous melanoma
The Lancet
June 1998
2nd International Conference on the AdjuvantTherapy of Malignant Melanoma London, UK, 1...
Melanoma Research
April 1997
7 Adjuvant therapy of malignant melanoma; the unreachable goal?
Melanoma Research
April 1997
21 Activity of Taxanes combined with Vinorelbine in disseminated malignant melanoma
Melanoma Research
April 1997
22 Adjuvant Vindesine in malignant melanoma (MM); 20 years on
Melanoma Research
April 1997
45 Activity of Docetaxel (D) and Vinorelbine (V) in vitro against human melanoma cell l...
Melanoma Research
April 1997
In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melano...
European Journal of Cancer
March 1997
Systemic treatment of malignant melanoma: grade is as important as stage
Clinical and Experimental Dermatology
March 1997
Systemic treatment of malignant melanoma: grade is as important as stage
Clinical and Experimental Dermatology
March 1997
The combination of paclitaxel with cisplatin exhibits antagonism in vitro against human...
Anti-Cancer Drugs
June 1996
Adjuvant interferon alfa-2b for high-risk melanoma.
Journal of Clinical Oncology
June 1996
Fertility after prolonged chemotherapy for metastatic malignant disease
The Lancet
March 1996
Taxol and vinorelbine
Anti-Cancer Drugs
March 1996
Cutaneous Melanoma-Associated Retinopathy
Journal of Neuro-Ophthalmology
March 1996
Malignant melanoma co-existing with sarcoidosis: implications for prognosis and management
Melanoma Research
February 1996
1st International Conference on the Adjuvant Therapy of Malignant Melanoma
Melanoma Research
December 1995
5 Clinical observations on the biology of malignant melanoma
Melanoma Research
December 1995
16 Clinical and histological involvement of regional lymph nodes in malignant melanoma
Melanoma Research
December 1995
Activity of Extracts ofKigelia pinnataAgainst Melanoma and Renal Carcinoma Cell Lines
Planta Medica
October 1994
Pharmaceuticals from plants
The Lancet
July 1994
Adjuvant interferon in melanoma
The Lancet
June 1994
Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell l...
Journal of Cancer Research and Clinical Oncology
April 1992
Metastasis to the penis from malignant melanoma: Case report and review of the literature
Clinical Oncology
January 1992
α-Interferons: Impact on survival of patients with renal cell carcinoma
Clinical Oncology
September 1991
Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-...
Clinical Oncology
May 1991
α-interferons: Impact on survival of patients with renal cell carcinoma
Clinical Oncology
January 1991
Intralesional tumour necrosis factor combined with interferon gamma in metastatic melan...
BMJ
May 1989
Missed malignant melanoma
BMJ
May 1986
Missed malignant melanoma
BMJ
May 1986
Malignant Melanoma: Prolonged Survival after Cerebral Metastasis
Journal of the Royal Society of Medicine
September 1985
Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced b...
BMJ
June 1984
Treatment of refractory malignant neoplasms with ifosfamide as single agent and in comb...
Cancer Treatment Reviews
September 1983
Evaluation of human lymphoblastoid interferon in advanced malignant melanoma
Cancer
January 1983
Updated results of vindesine as a single agent in the therapy of advanced malignant mel...
Cancer Treatment Reviews
September 1980
HEREDOPATHIA ATACTICA POLYNEURITIFORMIS (REFSUM'S DISEASE) TREATED BY DIET AND PLASMA-E...
The Lancet
March 1979
Vinca Alkaloids and Platelets
New England Journal of Medicine
August 1978
AGRANULOCYTOSIS IN BREAST-CANCER PATIENTS TREATED WITH LEVAMISOLE
The Lancet
August 1978
Symptom relief with levamisole in stage IV Hodgkin's disease.
BMJ
June 1977